ArticleThe Indian journal of medical research2026
Leptospiral uveitis: A late complication of systemic leptospirosis.
Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Leptospirosis is an important animal borne disease that primarily affects farmers in tropical countries. As a late complication, it causes ocular inflammation, uveitis. We are presenting ocular signs of leptospiral uveitis. Methods In this retrospective observational study, we have reviewed the data from clinical and laboratory records of microscopic agglutination test (MAT) positive, uveitis patients seen between 1994 and 2017 at the uveitis department of a university affiliated ophthalmology postgraduate institute in Tamil Nadu, South India. Results Out of a total of 75,150 new uveitis cases with different aetiologies seen in 24 years, 3,658 (4.9%) had clinical diagnosis of leptospiral uveitis. Of them, 1,268 (34.7%) patients were positive for leptospiral serological test. Of them, follow-up details were available for 876 patients. Of 876, 650 (74.2%) were men, 482 (55%) were farmers. 1224 eyes of 876 patients were found to have uveitis. The most common ocular signs were vitreous membranous opacities seen in 814 eyes (66.5%) followed by retinal phlebitis in 347 (28.4%), optic disc hyperaemia in 260 eyes (21.2%), and hypopyon in 208 eyes (17%). Active choroiditis/retinitis were never seen. Topical, oral or periocular steroid injections were used to treat uveitis. Inflammatory control was achieved in 96% of the patients. Two or more-line visual improvement was seen in 700 out of 740 (94.5%) eyes. Interpretation and conclusions Ocular involvement is an important immunological complication of systemic leptospirosis. Recognition of this entity is vital, especially in young males in whom other immunological uveitis are also common.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.